Philip J. Podrid

6.0k total citations · 1 hit paper
112 papers, 4.3k citations indexed

About

Philip J. Podrid is a scholar working on Cardiology and Cardiovascular Medicine, Emergency Medicine and Surgery. According to data from OpenAlex, Philip J. Podrid has authored 112 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Cardiology and Cardiovascular Medicine, 11 papers in Emergency Medicine and 6 papers in Surgery. Recurrent topics in Philip J. Podrid's work include Cardiac electrophysiology and arrhythmias (88 papers), Cardiac Arrhythmias and Treatments (54 papers) and Cardiac pacing and defibrillation studies (28 papers). Philip J. Podrid is often cited by papers focused on Cardiac electrophysiology and arrhythmias (88 papers), Cardiac Arrhythmias and Treatments (54 papers) and Cardiac pacing and defibrillation studies (28 papers). Philip J. Podrid collaborates with scholars based in United States, Italy and United Kingdom. Philip J. Podrid's co-authors include Bernard Lown, Thomas B. Graboys, Ernst A. Raeder, Steven Lampert, Vladimir Velebit, Bernice H. Cohen, Rodney H. Falk, Tomasz Fuchs, John S. Wilson and Joseph Stein and has published in prestigious journals such as New England Journal of Medicine, Circulation and Annals of Internal Medicine.

In The Last Decade

Philip J. Podrid

106 papers receiving 3.9k citations

Hit Papers

Aggravation and provocation of ventricular arrhythmias by... 1982 2026 1996 2011 1982 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip J. Podrid United States 36 3.8k 570 346 283 248 112 4.3k
D M Krikler United Kingdom 30 2.9k 0.8× 566 1.0× 373 1.1× 264 0.9× 181 0.7× 83 3.6k
Debra S. Echt United States 28 3.8k 1.0× 556 1.0× 359 1.0× 252 0.9× 354 1.4× 64 4.6k
Peter L. Friedman United States 41 5.8k 1.5× 781 1.4× 597 1.7× 439 1.6× 204 0.8× 117 6.5k
Edward Rowland United Kingdom 37 4.6k 1.2× 584 1.0× 499 1.4× 207 0.7× 220 0.9× 173 5.2k
James J. Heger United States 36 4.4k 1.2× 810 1.4× 664 1.9× 472 1.7× 156 0.6× 101 5.0k
R. W. F. Campbell United Kingdom 26 3.4k 0.9× 528 0.9× 325 0.9× 308 1.1× 158 0.6× 118 3.8k
Edward L.C. Pritchett United States 42 5.6k 1.5× 301 0.5× 755 2.2× 217 0.8× 77 0.3× 111 6.3k
Vincent DeQuattro United States 29 1.9k 0.5× 309 0.5× 452 1.3× 192 0.7× 117 0.5× 106 3.3k
H. Pouleur Belgium 34 3.3k 0.9× 423 0.7× 491 1.4× 703 2.5× 68 0.3× 150 3.9k
Leonard N. Horowitz United States 51 8.9k 2.3× 739 1.3× 1.1k 3.0× 464 1.6× 307 1.2× 163 9.4k

Countries citing papers authored by Philip J. Podrid

Since Specialization
Citations

This map shows the geographic impact of Philip J. Podrid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Podrid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Podrid more than expected).

Fields of papers citing papers by Philip J. Podrid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Podrid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Podrid. The network helps show where Philip J. Podrid may publish in the future.

Co-authorship network of co-authors of Philip J. Podrid

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Podrid. A scholar is included among the top collaborators of Philip J. Podrid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Podrid. Philip J. Podrid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Podrid, Philip J. & Robert J. Myerburg. (2009). Epidemiology and stratification of risk for sudden cardiac death. Clinical Cardiology. 28(S1). 3–11. 68 indexed citations
2.
Podrid, Philip J.. (1999). ATRIAL FIBRILLATION IN THE ELDERLY. Cardiology Clinics. 17(1). 173–188. 12 indexed citations
3.
Pedretti, Roberto F.E., et al.. (1998). Cost-Effectiveness Analysis of Invasive and Noninvasive Tests in High Risk Patients Treated With Amiodarone After Acute Myocardial Infarction. Journal of the American College of Cardiology. 31(7). 1481–1489. 3 indexed citations
4.
Podrid, Philip J.. (1997). Arrhythmias after acute myocardial infarction. Postgraduate Medicine. 102(5). 125–139. 6 indexed citations
5.
Levine, Glenn S., Philip J. Podrid, David J. Skorton, et al.. (1996). Books Received. Clinical Cardiology. 19(9). 762–762. 1 indexed citations
6.
Podrid, Philip J. & Jeffrey L. Anderson. (1996). Safety and Tolerability of Long-term Propafenone Therapy for Supraventricular Tachyarrhythmias. The American Journal of Cardiology. 78(4). 430–434. 31 indexed citations
7.
Levine, Glenn N. & Philip J. Podrid. (1995). The ECG Workbook: A Review and Discussion of ECG Findings and Abnormalities. Medical Entomology and Zoology. 1 indexed citations
8.
Falk, Rodney H. & Philip J. Podrid. (1992). Atrial fibrillation : mechanisms and management. 180 indexed citations
9.
Podrid, Philip J.. (1992). Therapy with and Assessment of Class III Antiarrhythmic Agents in Different Patient Populations. Journal of Cardiovascular Pharmacology. 20(Supplement). 44–58. 5 indexed citations
10.
Podrid, Philip J., et al.. (1991). Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine. The American Journal of Cardiology. 68(17). 1662–1667. 7 indexed citations
11.
Fogel, Richard I., et al.. (1991). Interactive ECG teaching system on the macintosh computer. Journal of the American College of Cardiology. 17(2). A10–A10.
12.
Mendes, Lisa A., Philip J. Podrid, Therese Fuchs, & Steve Franklin. (1991). Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardia. Journal of the American College of Cardiology. 17(6). 1396–1402. 11 indexed citations
13.
Ravid, Shmuel, Philip J. Podrid, Steven Lampert, & Bernard Lown. (1989). Congestive heart failure induced by six of the newer antiarrhythmic drugs. Journal of the American College of Cardiology. 14(5). 1326–1330. 56 indexed citations
14.
Horowitz, Leonard N., Douglas P. Zipes, J. Thomas Bigger, et al.. (1987). Proarrhythmia, arrhythmogenesis or aggravation of arrhythmia—A status report, 1987. The American Journal of Cardiology. 59(11). E54–E56. 25 indexed citations
15.
Podrid, Philip J.. (1985). Treatment of Ventricular Arrhythmia. CHEST Journal. 88(1). 121–128. 5 indexed citations
16.
Raeder, Ernst A., Philip J. Podrid, & Bernard Lown. (1985). Side effects and complications of amiodarone therapy. American Heart Journal. 109(5). 975–983. 167 indexed citations
17.
Podrid, Philip J. & Bernard Lown. (1984). Propafenone: A new agent for ventricular arrhythmia. Journal of the American College of Cardiology. 4(1). 117–125. 62 indexed citations
18.
Lampert, Steven, et al.. (1984). Lorcainide in patients with refractory ventricular tachyarrhythmia. Journal of the American College of Cardiology. 3(6). 1531–1539. 15 indexed citations
19.
Podrid, Philip J. & Bernard Lown. (1981). Mexiletine for ventricular arrhythmias. The American Journal of Cardiology. 47(4). 895–902. 88 indexed citations
20.
Lown, Bernard, et al.. (1977). Effect of a Digitalis Drug on Ventricular Premature Beats. New England Journal of Medicine. 296(6). 301–306. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026